Marc Engelsgjerd, MD, is Vice President, Search & Evaluation, at Royalty Pharma. Marc was previously the senior biotechnology equity research analyst at Bloomberg Intelligence. Prior to Bloomberg, Marc’s experience includes serving as oncology practice lead at inThought Research and time spent in equity research at Banc of America and UBS. Marc earned his medical degree at the UCSF School of Medicine followed by residency training at the Washington University School of Medicine and Brigham and Women’s Hospital. He received a Bachelor of Science degree with Honors in Molecular & Cellular Biology from the University of Arizona.